Eli Lilly’s big-selling insulin ... in vial form or as a disposable pen. Sanofi fights back This represents Sanofi's first foray into the biosimilar diabetes market, and has been persuaded ...
The U.S. Food and Drug Administration has approved Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback